Abstract
The molecular biology of aging has always been of extreme interest to researchers. Recent advances made through studies of model systems have greatly increased efforts to elucidate the mechanisms involved in aging. It now appears that in yeast there are two pathways controlling aging: i) the generation of extrachromosomal rDNA circles (ERCs) through the antagonistic action of Sir2p and Fob1p; and ii) the stress response pathway, regulated by the Sch9p and Tor1p kinases. The stress response pathway in higher eukaryotes is inhibited by the insulin-signaling pathway. Mutation to the AKT kinase disrupts insulin signaling and increases longevity. Yeast express orthologues of the insulin-signaling pathway, yet insulin is not a natural substrate for yeast. The yeast Sch9p is structurally and functionally related to the AKT kinase, but the remainder of the putative yeast AKT pathways is uncharacterized. Further mystery revolves around downstream targets that are directly required for longevity. Yeast provide an opportunity to investigate the function of the yeast AKT pathway at a molecular level. A potential downstream target has been identified in yeast that links the glucose and stress response pathways with lifespan: the Anaphase Promoting Complex (APC). This review will discuss the role the APC plays in established aging pathways in yeast and the implications on higher eukaryotes.
Keywords: Anaphase Promoting Complex, stress response pathway, caloric restriction, evolutionary conservation
Current Genomics
Title: The Anaphase Promoting Complex and Aging: The APCs of Longevity
Volume: 7 Issue: 4
Author(s): Troy A. A. Harkness
Affiliation:
Keywords: Anaphase Promoting Complex, stress response pathway, caloric restriction, evolutionary conservation
Abstract: The molecular biology of aging has always been of extreme interest to researchers. Recent advances made through studies of model systems have greatly increased efforts to elucidate the mechanisms involved in aging. It now appears that in yeast there are two pathways controlling aging: i) the generation of extrachromosomal rDNA circles (ERCs) through the antagonistic action of Sir2p and Fob1p; and ii) the stress response pathway, regulated by the Sch9p and Tor1p kinases. The stress response pathway in higher eukaryotes is inhibited by the insulin-signaling pathway. Mutation to the AKT kinase disrupts insulin signaling and increases longevity. Yeast express orthologues of the insulin-signaling pathway, yet insulin is not a natural substrate for yeast. The yeast Sch9p is structurally and functionally related to the AKT kinase, but the remainder of the putative yeast AKT pathways is uncharacterized. Further mystery revolves around downstream targets that are directly required for longevity. Yeast provide an opportunity to investigate the function of the yeast AKT pathway at a molecular level. A potential downstream target has been identified in yeast that links the glucose and stress response pathways with lifespan: the Anaphase Promoting Complex (APC). This review will discuss the role the APC plays in established aging pathways in yeast and the implications on higher eukaryotes.
Export Options
About this article
Cite this article as:
A. Harkness A. Troy, The Anaphase Promoting Complex and Aging: The APCs of Longevity, Current Genomics 2006; 7 (4) . https://dx.doi.org/10.2174/138920206778426997
DOI https://dx.doi.org/10.2174/138920206778426997 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Somatostatin, Somatostatin Analogs and Somatostatin Receptor Dynamics in the Biology of Cancer Progression
Current Molecular Medicine Between Bench and Bed Side: PI3K Inhibitors
Current Molecular Pharmacology Controversies of Dopamine Agonists: Somnolence, Cardiac Valvulopathy and Repetitive Behaviors
Current Drug Therapy Recent Developments in Group I Metabotropic Glutamate Receptor Allosteric Modulators for the Treatment of Psychiatric and Neurological Disorders (2014-May 2015)
Current Topics in Medicinal Chemistry Bone and the Kidney: A Systems Biology Approach to the Molecular Mechanisms of Renal Osteodystrophy
Current Molecular Medicine Biotechnology in the Development of New Vaccines and Diagnostic Reagents Against Tuberculosis
Current Pharmaceutical Biotechnology Signal transduction in Acute Myeloid Leukemia – Implications for Novel Therapeutic Concepts.
Current Cancer Drug Targets Strategies to Control Human Lymphatic Filarial Infection: Tweaking Host’s Immune System
Current Topics in Medicinal Chemistry The Role of Glucose in the Pathogenesis of Alzheimers Disease Revisited:What Does it Tell us About the Therapeutic use of Lithium?
Central Nervous System Agents in Medicinal Chemistry Readjusting the Glucocorticoid Balance: An Opportunity for Modulators of 11β -Hydroxysteroid Dehydrogenase Type 1 Activity?
Endocrine, Metabolic & Immune Disorders - Drug Targets Anesthesia Issues in Central Nervous System Disorders
Current Aging Science Pharmacogenomics of Essential Hypertension: Are We Going the Right Way?
Cardiovascular & Hematological Agents in Medicinal Chemistry Regulators of the G1 Phase of the Cell Cycle and Neurogenesis
Central Nervous System Agents in Medicinal Chemistry Association of Genetic Variation with Pneumonia
Current Respiratory Medicine Reviews The Main Receptors Involved in the COVID-19: A Systematic Review and Meta-Analysis
Current Medicinal Chemistry Genetic Polymorphisms of ATP-Binding Cassette Transporters ABCB1 and ABCC2 and their Impact on Drug Disposition
Current Drug Targets Neonatal Brain Hemorrhage (NBH) of Prematurity: Translational Mechanisms of the Vascular-Neural Network
Current Medicinal Chemistry Dopamine Receptor Pharmacology: Interactions with Serotonin Receptors and Significance for the Aetiology and Treatment of Schizophrenia
CNS & Neurological Disorders - Drug Targets Is An Oral Plant-based Vaccine against Hepatitis B Virus Possible?
Current Pharmaceutical Biotechnology Brain Serotonin, Psychoactive Drugs, and Effects on Reproduction
Central Nervous System Agents in Medicinal Chemistry